Ocumetra logo

Ocumetra

Revolutionising Myopia Management I Communication and Clinical Decision Support Tools for Eye Care Professionals

17 employees · est. 2021 · Ireland

VS
Sydnexis logo

Sydnexis

We focus on developing a best-in-class low-dose atropine formulation to address the juvenile-onset myopia pandemic.

16 employees · est. 2014

Sydnexis is the older company (2021 vs 2014).

Side-by-Side Comparison

Ocumetra Sydnexis
Founded
2021 2014 older
Headquarters
Ireland Not tracked yet
Employees
17 16
Industry
Analytics, Health Care, Information Technology Manufacturing, Pharmaceutical
Funding Stage
Not tracked yet Series B
Total Funding
Not tracked yet $50.50M
Funding Rounds
Not tracked yet 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Eye Health, Myopia Management, Clinical Decision Support, Patient Communication, Educational Tools, Software Development, Optometry Ophthalmology, Pediatric Healthcare, Pharmaceuticals, Myopia Treatment, Atropine Formulation, Optometry, Ocular Health, Medical Innovation, Child Health, Vision Care, Clinical Research, Eye Care, Drug Development, Healthtech, Global Health
Website
ocumetra.com sydnexis.com
Ocumetra logo

About Ocumetra

Ocumetra is a data analytics company founded in 2021 based in Ireland. The company's slogan "Revolutionising Myopia Management I Communication and Clinical Decision Support Tools for Eye Care Professionals" encapsulates its mission to provide communication tools and clinical decision support to eye...

Sydnexis logo

About Sydnexis

Sydnexis is a pharmaceutical startup founded in 2014 with the mission to combat the increasing prevalence of myopia among children. The company's focus is on developing a proprietary, stable, low-dose atropine eyedrop to treat myopia progression and reduce the risk of ocular co-morbidities. With the...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Ocumetra and Sydnexis — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Ocumetra and Sydnexis — by email.

Frequently Asked Questions

Ocumetra — Revolutionising Myopia Management I Communication and Clinical Decision Support Tools for Eye Care Professionals. Sydnexis — We focus on developing a best-in-class low-dose atropine formulation to address the juvenile-onset myopia pandemic.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Ocumetra has raised undisclosed funding while Sydnexis has raised $50.50M.
Ocumetra and Sydnexis operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Ocumetra with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy